Strategic Advocates’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.93K Sell
7
-6
-46% -$1.7K 0.01% 210
2026
Q1
$3.47K Sell
13
-511
-98% -$141K 0.02% 199
2025
Q4
$145K Buy
524
+103
+24% +$28.9K 0.04% 135
2025
Q3
$121K Buy
+421
New +$125K 0.03% 155
2025
Q1
Sell
-1,008
Closed -$278K 117
2024
Q4
$278K Sell
1,008
-262
-21% -$83.5K 0.09% 84
2024
Q3
$440K Buy
+1,270
New +$437K 0.16% 78

Other funds holding CI

Strategic Advocates's CI Position: Q2 2026 in Review

Strategic Advocates reduced its Cigna (CI) stake by 46% in Q2 2026, selling an estimated $1.7K and leaving 7 shares worth $1.93K. The position accounts for 0.01% of the portfolio, ranked #210.

Strategic Advocates first reported a position in CI in Q3 2024 and has held it in 6 quarters since. The position peaked at $440K in Q3 2024. 1,700 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Strategic Advocates held 7 shares of Cigna worth $1.93K as of Q2 2026.
  • Strategic Advocates sold 6 Cigna shares in Q2 2026, an estimated $1.7K.
  • Cigna made up 0.01% of Strategic Advocates's portfolio in Q2 2026, its #210 holding.
  • Strategic Advocates first reported a position in Cigna in Q3 2024 and has held it in 6 quarters since.
  • Strategic Advocates's Cigna position peaked at $440K in Q3 2024.
  • 1,700 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Strategic Advocates's 13F filing for Q2 2026, filed 13 Aug 2026.